Lobe Sciences Ltd. will participate in the 3rd Annual ArcStone-Kingswood Growth Summit in Toronto on September 16, 2026. CFO Dr. David Kideckel will meet investors to discuss Lobe's lead drug candidate L-130, designed for cluster headaches and other neuropsychiatric disorders, and S-100 for sickle cell disease. The summit offers Lobe a platform to connect with Canadian and U.S. investors and advance its clinical-stage biotechnology programs. This event could boost investor interest and support for Lobe's novel therapies targeting neurological and rare diseases.
Lobe Sciences attending the ArcStone-Kingswood Growth Summit 2026 in Toronto is the subject, with Pluang's health sector market snapshot as of Sep 14, 2026 18:52 WIB: Among 91 priced US health stocks, 50 rose and 28 fell. Notable movers include Sanofi SA (SNY) at USD 43.50 with a +1.71% change, Alcon AG (ALC) at USD 67.13 with +1.67%, and Inovio Pharmaceuticals Inc (INO) at USD 1.23 with -1.60%.
Marvell's stock rose 5.8% after the company revealed an ambitious revenue forecast targeting $70-$90 billion by fiscal 2031, driven by AI infrastructure, custom chips, and connectivity products. Several analysts raised their price targets, with Jeffe...
Following the Federal Reserve's interest rate increase on September 16, US bank stocks saw a decline in valuations. Despite this, the S&P US BMI Banks index slightly rose by 0.1% from August 31 to September 15, outperforming the S&P 500 which fell by...
US Treasury yields climbed early Wednesday with the 10-year note yield up to 5.307% and the 30-year bond yield rising to 5.69%. Investors are awaiting a $39 billion 10-year note auction and the Federal Reserve's meeting minutes, which may provide clu...
Avalanche (AVAX) was trading around $11.27 on October 7, showing a mixed technical setup with momentum indicators varying. The token remained significantly above its 50-day and 200-day moving averages, suggesting some underlying strength. However, it...
Chevron CEO Mike Wirth cautioned against a U.S. diesel export ban, calling it unwise as it could worsen supply pressures and damage confidence in the U.S. as a reliable energy supplier. This comes amid ongoing tensions in the U.S.-Iran conflict disru...
